Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 2Phase NA 1Phase 2 1Phase 1/2 1

Status

Terminated 3Recruiting 2Completed 2Withdrawn 1

Sponsor Class

OTHER 6NETWORK 1INDUSTRY 1

Study Type

Interventional 8

Sponsor

Cancer Type

Other hematologic neoplasm 9Lymphoid 8Genitourinary 8Gastrointestinal 7Plasma cell 5Classical hematology 3Breast 3Dermatologic 2Other solid neoplasm 1Other neoplasm 1Myeloid 1Head & Neck 1CNS 1

Conditions

Prostatic Neoplasms 5Urinary Tract Infections 1Urinary Bladder Neoplasms 1Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1Infections 1Cystectomy 1

Interventions

Docetaxel 390pembrolizumab 326Prednisone 285Gemcitabine 273enzalutamide 256Radiotherapy 251Nivolumab 248Magnetic Resonance Spectroscopy 247Cisplatin 209Abiraterone Acetate 198Radiosurgery 184Leuprolide 182Sunitinib 169Carboplatin 161bicalutamide 148Goserelin 145Androgen Antagonists 142Specimen Handling 138Ipilimumab 128Paclitaxel 125Cyclophosphamide 116acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 110Bevacizumab 109Everolimus 107apalutamide 99abiraterone 99cabozantinib 98atezolizumab 97Sorafenib 97Radiation 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Interventional × Ciprofloxacin × Genitourinary × Clear all
NCT06126731 2025-11-24

Combination Study of Antibiotics With Enzalutamide (PROMIZE)

Institute of Cancer Research, United Kingdom

Phase 1/2 Recruiting
39 enrolled
Genitourinary

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT03862170 2025-02-12

BRP30

CR-CSSS Champlain-Charles-Le Moyne

Phase 3 Terminated
158 enrolled
Genitourinary

Prostatic Neoplasms

NCT06709196 2025-01-09

REINFORCE

Rigshospitalet, Denmark

Phase 4 Recruiting
248 enrolled
Genitourinary

Cystectomy

NCT03228108 2022-05-10

pro-SWAP

Radboud University Medical Center

Phase 4 Completed
1,538 enrolled
Genitourinary

Infections, Prostatic Neoplasms

NCT02252978 2018-07-05

Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy

Wake Forest University Health Sciences

Phase 2 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT02247960 2017-04-17

Abx

University of Rochester

Phase NA Terminated
175 enrolled 7 charts
Genitourinary

Prostatic Neoplasms, Urinary Tract Infections

NCT01649635 2016-07-06

PROSPECTA

Sanofi

Phase 4 Completed
45 enrolled
Genitourinary

Prostatic Neoplasms

NCT00003824 2012-03-09

S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

SWOG Cancer Research Network

Phase 3 Terminated
114 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡